Daniel Javitt
Oprichter bij NeuroRx, Inc.
Vermogen: 3 M $ op 30-04-2024
Actieve functies van Daniel Javitt
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
NeuroRx, Inc.
 NeuroRx, Inc. BiotechnologyHealth Technology NeuroRx, Inc. operates as a clinical stage, small molecule pharmaceutical company developing novel therapeutics for the treatment of central nervous system disorders. The company was founded by Jonathan C. Javitt and Daniel C. Javitt in 2015 and is headquartered in Wilmington, DE. | Voorzitter | 01-01-2015 | - |
| Oprichter | 01-01-2015 | - |
Loopbaan van Daniel Javitt
Statistieken
Internationaal
| Verenigde Staten | 2 |
Operationeel
| Chairman | 1 |
| Founder | 1 |
Sectoraal
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
NeuroRx, Inc.
NeuroRx, Inc. BiotechnologyHealth Technology NeuroRx, Inc. operates as a clinical stage, small molecule pharmaceutical company developing novel therapeutics for the treatment of central nervous system disorders. The company was founded by Jonathan C. Javitt and Daniel C. Javitt in 2015 and is headquartered in Wilmington, DE. | Health Technology |
- Beurs
- Insiders
- Daniel Javitt
- Ervaring
